Last reviewed · How we verify

NCT04393064: FEES

Fiberoptic Endoscopic Evaluation of Swallowing(FEES) in Infants Graduated From (NICU) Neonatal Intensive Care Unite

Status unknown NA Last updated 21 July 2020
What this trial tests

NA trial testing fiberoptic endoscopic evaluation of swallowing in Fiberoptic Endoscope Evaluation of Swallowing in Infants(FEES) in 150 participants. Status unknown.

Timeline
1 December 2017
Primary endpoint
1 October 2020
1 December 2020

Quick facts

Lead sponsorCairo University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment150
Start date1 December 2017
Primary completion1 October 2020
Estimated completion1 December 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 1 Day to 6 Months, any sex, with Fiberoptic Endoscope Evaluation of Swallowing in Infants(FEES). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Based on study showing the ability of using FEES in infant in NICU; so the aim of this study to screen the newborns graduated from NICU using clinical bed side evaluation as well as flexible endoscopic assessment of swallowing to identify the ones suffering from oropharyngeal and / or esophageal dysphagia as well as newborns at risk for aspiration \&aspiration pneumonia to tailor or identify appropriate feeding plan for those high risk popularities and support them

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of fiberoptic endoscopic evaluation of swallowing

Trials testing the same drug.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04393064.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing